Benefits Of Using Various Starting Doses Of Atorvastatin On Achievement Of Cholesterol Targets

NCT00442325 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

595

Enrollment

INDUSTRY

Sponsor class

Conditions

Coronary Arteriosclerosis
Diabetes Mellitus, Type 2
Cerebrovascular Accident
Dyslipidemia
Peripheral Vascular Disease

Interventions

DRUG: Atorvastatin (Lipitor)

Sponsor

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.